Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Depreciation & Amortization (CF): 2021-2022

Historic Depreciation & Amortization (CF) for Burning Rock Biotech (BNR) over the last 1 years, with Mar 2022 value amounting to $809,703.

  • Burning Rock Biotech's Depreciation & Amortization (CF) rose 2447.86% to $809,703 in Q1 2022 from the same period last year, while for Mar 2022 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $7.2 million for FY2024, which is 61.94% down from last year.
  • As of Q1 2022, Burning Rock Biotech's Depreciation & Amortization (CF) stood at $809,703, which was up 161.32% from $309,847 recorded in Q4 2021.
  • Burning Rock Biotech's 5-year Depreciation & Amortization (CF) high stood at $809,703 for Q1 2022, and its period low was $31,780 during Q1 2021.
  • In the last 2 years, Burning Rock Biotech's Depreciation & Amortization (CF) had a median value of $213,630 in 2021 and averaged $286,518.
  • Data for Burning Rock Biotech's Depreciation & Amortization (CF) shows a peak YoY soared of 2,447.86% (in 2022) over the last 5 years.
  • Burning Rock Biotech's Depreciation & Amortization (CF) (Quarterly) stood at $309,847 in 2021, then skyrocketed by 2,447.86% to $809,703 in 2022.
  • Its Depreciation & Amortization (CF) stands at $809,703 for Q1 2022, versus $309,847 for Q4 2021 and $213,630 for Q3 2021.